A Pharmacokinetic and Tolerability Study of Fexinidazole in a Single Oral Dose in Adult Participants With Mild and Moderate Hepatic Impairment

Clinical trial NCT05607173 · COMPLETED

Trial details

NCT number: NCT05607173
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Function Abnormal

Start date: 2023-01-18
Primary completion: 2023-05-03
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.